NRD
ICUI icon

Nebula Research & Development’s ICU Medical ICUI Stock Holding History

Nebula Research & Development’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,386
Closed -$425K – 568
2023
Q2 		$425K Buy
+2,386
New +$438K 0.32% 162

Other funds holding ICUI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nebula Research & Development's ICUI Position: Q3 2023 in Review

Nebula Research & Development sold out of ICU Medical (ICUI) in Q3 2023, closing a stake of 2,386 shares — an estimated $425K sold.

Nebula Research & Development first reported a position in ICUI in Q2 2023 and held it in 1 quarter. The position peaked at $425K in Q2 2023. 220 funds tracked by Wall St. Rank hold ICUI as of Q3 2023.

  • Nebula Research & Development reported no remaining ICU Medical position as of Q3 2023 after selling out during the quarter.
  • Nebula Research & Development sold 2,386 ICU Medical shares in Q3 2023, an estimated $425K.
  • Nebula Research & Development first reported a position in ICU Medical in Q2 2023 and held it in 1 quarter.
  • Nebula Research & Development's ICU Medical position peaked at $425K in Q2 2023.
  • 220 funds tracked by Wall St. Rank held ICU Medical as of Q3 2023.

Based on Nebula Research & Development's 13F filing for Q3 2023, filed 14 Nov 2023.